Long-term safety and antitumor activity in the phase 1-2 study of enzalutamide in pre- and post-docetaxel castration-resistant prostate cancer

Celestia S. Higano, Tomasz M. Beer, Mary Ellen Taplin, Eleni Efstathiou, Mohammad Hirmand, David Forer, Howard I. Scher

Research output: Contribution to journal › Article › peer-review

41 Scopus citations

Fingerprint

Dive into the research topics of 'Long-term safety and antitumor activity in the phase 1-2 study of enzalutamide in pre- and post-docetaxel castration-resistant prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences